Global Cell Based Assay Market Global Cell Based Assay Market

Global Cell Based Assay Market – Positive long term growth
outlook 2016-21
According to the report Cell based assay Market, published by Market Data Forecast, the global
market is projected to reach USD 17.85 billion by 2021, at a CAGR of 11.2 % from 2016 to 2021.
Cell-based assays are essential for studying cellular mechanisms in a biological context. A variety
of such assays using fluorescence technologies are already available to cover many applications
including assessing cellular functions and processes in biological research and for toxicity
studies.
Get accurate market forecast and analysis on the Cell Based Assay Market. Request a free
sample to stay up-to-date on the main trends affecting this
market: http://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-
2218/request-sample
While most of the knowledge we have about cell biology and the underlying molecular
processes evolved using biochemical assays, cell-based assays are now most widely used. These
assays have the potential to provide more information about intracellular molecular targets and
have the advantage of being performed in a truly biological context. In addition, the
combination of cell based assays with fluorescence technologies makes them applicable to high
throughput screening processes. With the current advances in high resolution microscopy, high
content analysis (HCA), and the availability of major stem cell-derived research tools, it is now
easily possible to study detailed cellular mechanisms in a biologically relevant context with
confidence.
Get a comprehensive overview of the Cell Based Assay Market:
http://www.marketdataforecast.com/market-reports/global-cell-based-assay-market-2218/
Cell Based Assay Market: Drivers & Restraints
Cell based assay market growth is likely to propagate in the future as per current trends of
increase in the demand for research initiatives in drug discovery. Government initiatives
introduced for the sole purpose of technical advancements and developments to meet the
increase in demand for biological drugs over the last couple of years is propelling the market.
The increase in average spending for healthcare and especially for such fields has been noted
and are expected to continue to positively benefit the market. Public demand for decreased cost
of drugs has prompted the market leaders to continue to add a number of new drugs to their
pipeline to satisfy all such demands. Problems regarding intellectual property rights and the
strict laws regarding such issues may continue to act as shackles to the growth of the market